Uterus Transplantation From Deceased Donor - Gothenburg III
NCT ID: NCT03581019
Last Updated: 2024-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1 participants
INTERVENTIONAL
2018-06-17
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Uterus Transplantation by Robotics - Gothenburg III
NCT05089513
Uterus Transplantation From Live Donors With Robotic Assisted Surgery - Gothenburg II
NCT02987023
Living Donor Uterus Transplantation Between Identical Twins
NCT03138226
Acceptance of Uterus Transplantation
NCT03048396
Uterus Transplantation From Live Donor
NCT01844362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uterus transplantation
Uterus transplantation
uterus transplantation
uterus transplantation from deceased donor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
uterus transplantation
uterus transplantation from deceased donor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* initially included and excluded by early graft failure of Gothenburg I or II
* age \< 40 years
* no systemic disease
* no standing medication
* satisfactory ovarian reserve
* BMI \<35 and at BMI 30-35 waist circumference of \< 82 cm
* absolute uterine factor infertility
* psychological stable
* brain death and suitable as multiorgan donor
* acceptance for donation of uterus from family or previously by patient
* age \<55 years
* at least one normal pregnancy and childbirth
* no previos malignancy
* no systemic disease
* no previous major surgery inn abdomen or on uterus
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mats Brännström
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mats Brännström
Role: PRINCIPAL_INVESTIGATOR
Göteborg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska University Hospital
Gothenburg, , Sweden
Mats Brännström
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sahlgrenska-DD-UTx
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.